Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Thinzar M Lwin
Affiliation
City of Hope National Medical Center
ORCID
Career Start Year
2011
Papers
55
H Index
14
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37839102
Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
J Surg Res
2024
36056196
ASO Visual Abstract: Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.
Ann Surg Oncol
2023
37845517
Fluorescence lifetime of injected indocyanine green as a universal marker of solid tumours in patients.
Nat Biomed Eng
2023
37540977
PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
J Surg Res
2023
37320867
Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model.
Tissue Cell
2023
37121988
Surgical Utilization and Outcomes for Patients with Stage IV Melanoma in the Modern Immunotherapy Era.
Ann Surg Oncol
2023
37185743
Specific Targeting and Labeling of Colonic Polyps in <i>CPC-APC</i> Mice with Mucin 5AC Fluorescent Antibodies: A Model for Detection of Early Colon Cancer.
Curr Issues Mol Biol
2023
37248378
ASO Visual Abstract: Surgical Utilization and Outcomes for Patients with Stage 4 Melanoma in the Modern Immunotherapy Era.
Ann Surg Oncol
2023
37341873
Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
Mol Imaging Biol
2023
37269799
Robotic Function-Preserving Resection of Gastric Gastrointestinal Stromal Tumor.
J Surg Res
2023
37225835
ASO Author Reflections: The Evolution of Surgery for Patients with Stage IV Melanoma.
Ann Surg Oncol
2023
36900282
The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer.
Cancers (Basel)
2023
36728297
Four-Day Robotic Whipple: Early Discharge after Robotic Pancreatoduodenectomy.
J Am Coll Surg
2023
36057899
Proof of Principle of Combining Fluorescence-Guided Surgery with Photoimmunotherapy to Improve the Outcome of Pancreatic Cancer Therapy in an Orthotopic Mouse Model.
Ann Surg Oncol
2023
34407918
Rapid intraoperative perfusion assessment of parathyroid adenomas with ICG using a wide-field portable hand-held fluorescence imaging system.
Am J Surg
2022
35625638
Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
Biomolecules
2022
35715267
Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.
Am J Surg
2022
35927078
Proof of concept of improved fluorescence-guided surgery of colon cancer liver metastasis using color-coded imaging of a tumor-labeling fluorescent antibody and indocyanine green restricted to the adjacent liver segment.
Surgery
2022
34972700
Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
In Vivo
2022
35302604
First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes.
Clin Cancer Res
2022
35053365
Fluorescence Molecular Targeting of Colon Cancer to Visualize the Invisible.
Cells
2022
34309885
Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
J Surg Oncol
2021
33848831
A Novel Color-Coded Liver Metastasis Mouse Model to Distinguish Tumor and Adjacent Liver Segment.
J Surg Res
2021
33670740
Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery.
Biomolecules
2021
34944463
The Use of Fluorescent Anti-CEA Antibodies to Label, Resect and Treat Cancers: A Review.
Biomolecules
2021
34182469
A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
In Vivo
2021
32370916
Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
Surgery
2020
33163512
Fluorescence-guided hepatobiliary surgery with long and short wavelength fluorophores.
Hepatobiliary Surg Nutr
2020
32416765
The future of tumour-specific fluorescence-guided surgery for pancreatic cancer.
Lancet Gastroenterol Hepatol
2020
31077946
Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.
J Surg Res
2019
31519565
Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model.
Anticancer Res
2019
31254333
Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors.
J Biomed Opt
2019
31366489
Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
Anticancer Res
2019
31188174
RE: "Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection".
Ann Surg
2019
30953192
Tumor-targeting Salmonella typhimurium A1-R overcomes nab-paclitaxel resistance in a cervical cancer PDOX mouse model.
Arch Gynecol Obstet
2019
29191280
Rare, Uncommon, and Unusual Complications After Pancreaticoduodenal Resection.
Surg Clin North Am
2018
30080930
Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
J Surg Oncol
2018
29857821
MEK inhibitor trametinib in combination with gemcitabine regresses a patient-derived orthotopic xenograft (PDOX) pancreatic cancer nude mouse model.
Tissue Cell
2018
30324479
ASO Author Reflections: Fluorescent Anti-CEA IR800 for Tumor Labeling.
Ann Surg Oncol
2018
30647873
Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.
Oncotarget
2018
29768067
The development of fluorescence guided surgery for pancreatic cancer: from bench to clinic.
Expert Rev Anticancer Ther
2018
29372363
Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Ann Surg Oncol
2018
29623758
Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
Cell Cycle
2018
29129358
Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.
Surgery
2018
28011474
Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.
Anticancer Res
2017
28441080
Color-coded intravital imaging demonstrates a transforming growth factor-β (TGF-β) antagonist selectively targets stromal cells in a human pancreatic-cancer orthotopic mouse model.
Cell Cycle
2017
28404944
Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model.
Oncotarget
2017
28296559
The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80Â years ago.
Cell Cycle
2017
28468988
ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
J Cell Sci
2017
29034343
Regarding the applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.
Transl Gastroenterol Hepatol
2017
1 - 50 of 55
Column Actions
Search
Recommended Authors
Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year
2017
Number of shared co-authors
0
Alex B Blair
Johns Hopkins University School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Fan Zhang
The Second Hospital of Dalian Medical University
Career Start Year
2010
Number of shared co-authors
0
Lei Zhu
Emory University School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Jeroen A C M Goos
Karolinska Institutet
Career Start Year
2009
Number of shared co-authors
0
Nimit L Patel
Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc.
Career Start Year
2008
Number of shared co-authors
0
Pedram Heidari
Massachusetts General Hospital
Career Start Year
2008
Number of shared co-authors
0
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year
2005
Number of shared co-authors
0
Xiaoyuan Chen
Institute of Molecular and Cell Biology
Career Start Year
2004
Number of shared co-authors
0
Hak Soo Choi
Massachusetts General Hospital, Harvard Medical School
Career Start Year
2001
Number of shared co-authors
0
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year
2001
Number of shared co-authors
0
Trevor D McKee
University Health Network
Career Start Year
2001
Number of shared co-authors
0
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year
1999
Number of shared co-authors
0
Thomas J George
UF Health Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Gang Niu
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year
1997
Number of shared co-authors
0
Nobuyuki Kosaka
University of Fukui.
Career Start Year
1997
Number of shared co-authors
0
Antonio Cubillo
Hospital HM Universitario Sanchinarro
Career Start Year
1997
Number of shared co-authors
0
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
0
Syed A Ahmad
University of Cincinnati College of Medicine
Career Start Year
1996
Number of shared co-authors
1
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year
1996
Number of shared co-authors
0
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Career Start Year
1995
Number of shared co-authors
1
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
0
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year
1991
Number of shared co-authors
0
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year
1991
Number of shared co-authors
0
Richard J Barth
Dartmouth-Hitchcock Medical Center
Career Start Year
1990
Number of shared co-authors
0
Hisataka Kobayashi
Center for Cancer Research
Career Start Year
1990
Number of shared co-authors
0
Martin D McCarter
University of Colorado School of Medicine
Career Start Year
1989
Number of shared co-authors
1
James P Basilion
Case Western Reserve University
Career Start Year
1985
Number of shared co-authors
0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year
1983
Number of shared co-authors
0
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year
1982
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Michael Bouvet
Co-authored papers
44
Robert M Hoffman
Co-authored papers
38
George Molina
Center for Surgery and Public Health, Brigham and Women's Hospital
Co-authored papers
3
Arun S Singh
University of California-Los Angeles
Co-authored papers
2
Fritz C Eilber
University of California, Los Angeles David Geffen School of Medicine
Co-authored papers
2
Scott D Nelson
University of California-Los Angeles
Co-authored papers
2
Jihoon Kim
university of california san diego
Co-authored papers
2
Jing Yang
University of California San Diego
Co-authored papers
2
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers
2
Mark A Eckert
Medical University of South Carolina
Co-authored papers
2
Thomas J Savides
University of California San Diego
Co-authored papers
1
Brian V Nahed
Harvard Medical School
Co-authored papers
1
Andrew T Chang
Rice University
Co-authored papers
1
Sara A Courtneidge
Oregon Health & Science University
Co-authored papers
1
Lucila Ohno-Machado
Co-authored papers
1
Erin Ward
Boston Children's Hospital
Co-authored papers
1
Etienne Danis
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Lucila Ohno-Machado
Escola de Administracao de Empresas - FGV, Stanford University, University of California San Diego, University of Sao Paulo, Yale School of Medicine
Co-authored papers
1
Andrew M Lowy
University of California San Diego
Co-authored papers
1
1 - 19